Candel Therapeutics Inc. (CADL)
7.62
-0.22 (-2.81%)
At close: Jan 15, 2025, 3:48 PM
Ratios (Annual)
Discover comprehensive ratio statement breakdowns that reveal insights into revenue, expenses, and beyond.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 |
| PE Ratio | -1.12 | -18 | -6.2 | -9.2 | -25.46 |
| PS Ratio | n/a | 412.75 | 1.79K | 1.63K | 1.63K |
| PB Ratio | 3.34 | -0.52 | 3.50 | -8.66 | -25.38 |
| P/FCF Ratio | -1.23 | -1.58 | -9.33 | -19.35 | -38.24 |
| P/OCF Ratio | -1.24 | -1.64 | -10.1 | -22.49 | -39.41 |
| OCF/S Ratio | n/a | -251.35 | -177.74 | -72.57 | -41.42 |
| Debt / Equity Ratio | 1.79 | -0.23 | 0.01 | -0.04 | -0.05 |
| Quick Ratio | 2.59 | 12.81 | 15.84 | 7.46 | 32.06 |
| Current Ratio | 2.59 | 12.81 | 15.84 | 7.46 | 32.06 |
| Asset Turnover | n/a | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Coverage | -74.69 | -70.86 | -485.4 | n/a | n/a |
| Return on Equity (ROE) | -2.98 | 0.03 | -0.56 | 0.94 | 1.00 |
| Return on Assets (ROA) | -0.92 | -0.04 | -0.41 | -0.58 | -0.17 |
| Return on Capital (ROIC) | -1.42 | -0.48 | -0.31 | -0.41 | -0.2 |
| Dividend Yield | n/a | n/a | n/a | n/a | n/a |
| Payout Ratio | n/a | n/a | n/a | n/a | n/a |
| Gross Profit Margin | n/a | -689.6% | -85.6% | 100.00% | -5.19K% |
| Net Profit Margin | n/a | -2.29K% | -28.94K% | -17.74K% | -6.41K% |
| Pretax Profit Margin | n/a | -15.04K% | -28.90K% | -14.14K% | -6.59K% |
| Operating Profit Margin | n/a | -27.78K% | -20.58K% | -11.05K% | -7.23K% |
| FCF Margin | n/a | -26.17K% | -19.24K% | -8.44K% | -4.27K% |
| EBITDA Margin | n/a | -13.85K% | -20.40K% | -10.98K% | -6.56K% |